- Direction
- Deteriorating
- Own history
- —
- Peers
- 81th
- Persistence
- EMERGING
· Pharmaceutical Preparations
RESEARCH SNAPSHOTPhathom Pharmaceuticals, Inc.'s latest supported as-filed period reports revenue of $84.7M; gross margin moved 757 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 195.39% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.13% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 2.17% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 71.14% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 9.01% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 78.32% · CORE
Level · gp.fundamentals.operating_margin
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 22.0%; Operating cash flow increased 96.9%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 36.6%; Operating cash flow changed across a sign change.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 88.0%; Operating margin moved 14636 bp higher; Operating income increased 93.4%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 71.1%; Operating margin moved 3075 bp higher; Operating income increased 99.4%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 124.8%; Inventory / revenue moved 170 bp higher.
2 evidence-backed componentsFree-cash-flow proxy changed +96.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
PHAT · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-436961SEC ↗8-KOct 29, 2026Period Oct 29, 20260001193125-26-436959SEC ↗8-KOct 26, 2026Period Oct 26, 20260001193125-26-430977SEC ↗8-KOct 23, 2026Period Oct 23, 20260001193125-26-430621SEC ↗4Oct 8, 2026Period Oct 6, 20260001193125-26-418114SEC ↗8-KSep 29, 2026Period Sep 29, 20260001193125-26-407696SEC ↗4Sep 8, 2026Period Sep 3, 20260001193125-26-385250SEC ↗10-QTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 6, 2026Filed Oct 8, 2026 | Narula SanjeevChief Financial & Bus. Officer | Tax WithholdingDirect | 13,485 | $7 | $91,428 | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | Breedlove Robert CharlesPrincipal Accounting Officer | Tax WithholdingDirect | 460 | $9 | $4,163 | Form 4 ↗ |
| Jul 14, 2026Filed Jul 16, 2026 | Breedlove Robert CharlesPrincipal Accounting Officer | Tax WithholdingDirect | 1,555 | $11 | $17,159 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value -0.10% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 10.32% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 6.99% · OPTIONAL
Operating cash flow changed +96.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +48.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +43.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed -757 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed -918 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Debt / assets changed -3166 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-324867